A Review of Ranibizumab for the Treatment of Diabetic Retinopathy.
about
Inhibition of YAP ameliorates choroidal neovascularization via inhibiting endothelial cell proliferation.Treatment of Diabetic Macular Edema with Intravitreal Antivascular Endothelial Growth Factor and Prompt versus Deferred Focal Laser during Long-Term Follow-Up and Identification of Prognostic Retinal Markers
P2860
A Review of Ranibizumab for the Treatment of Diabetic Retinopathy.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
A Review of Ranibizumab for the Treatment of Diabetic Retinopathy.
@ast
A Review of Ranibizumab for the Treatment of Diabetic Retinopathy.
@en
type
label
A Review of Ranibizumab for the Treatment of Diabetic Retinopathy.
@ast
A Review of Ranibizumab for the Treatment of Diabetic Retinopathy.
@en
prefLabel
A Review of Ranibizumab for the Treatment of Diabetic Retinopathy.
@ast
A Review of Ranibizumab for the Treatment of Diabetic Retinopathy.
@en
P2860
P1476
A Review of Ranibizumab for the Treatment of Diabetic Retinopathy.
@en
P2093
Michael W Stewart
P2860
P2888
P356
10.1007/S40123-017-0083-9
P577
2017-03-21T00:00:00Z
P6179
1084038330